InvestSMART

Imugene Limited (ASX: IMU) - Announcements

Current share price for IMU : $0.082 0.001 (1.20%)+

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$40 Change of Director's Interest Notice - PH 4 Oct 2023 7:25PM $0.044 $0.082 risen by 86.36%
$40 Change of Director's Interest Notice - JD 4 Oct 2023 7:18PM $0.044 $0.082 risen by 86.36%
$40 Change of Director's Interest Notice - JE 4 Oct 2023 7:17PM $0.044 $0.082 risen by 86.36%
$40 Change of Director's Interest Notice - KD 4 Oct 2023 7:15PM $0.044 $0.082 risen by 86.36%
$40 Change of Director's Interest Notice - LR 4 Oct 2023 7:15PM $0.044 $0.082 risen by 86.36%
$40 Change of Director's Interest Notice - LC 4 Oct 2023 7:08PM $0.044 $0.082 risen by 86.36%
$40 Cleansing Notice 3 Oct 2023 11:59AM $0.048 $0.082 risen by 72.63%
$40 Application for quotation of securities - IMU 3 Oct 2023 11:56AM $0.048 $0.082 risen by 72.63%
$40 Distribution Schedule and Top 20 3 Oct 2023 11:54AM $0.048 $0.082 risen by 72.63%
$40 Application for quotation of securities - IMU 3 Oct 2023 11:51AM $0.048 $0.082 risen by 72.63%
$40 Imugene ESG Report 2023 29 Sep 2023 4:36PM $0.046 $0.082 risen by 78.26%
$40 Appendix 4G 29 Sep 2023 4:35PM $0.046 $0.082 risen by 78.26%
$40 Corporate Governance Statement 2023 29 Sep 2023 4:32PM $0.046 $0.082 risen by 78.26%
$40 Preliminary Final Report - Reporting Adjustments 29 Sep 2023 4:20PM $0.046 $0.082 risen by 78.26%
$40 Annual Report to shareholders 29 Sep 2023 4:19PM $0.046 $0.082 risen by 78.26%
$40 Results of Extraordinary General Meeting 28 Sep 2023 3:51PM $0.047 $0.082 risen by 76.34%
$40 CEO Presentation to the EGM 28 Sep 2023 9:30AM $0.050 $0.082 risen by 64%
$40 Azer-cel FDA IND Transferred to Imugene 28 Sep 2023 9:15AM $0.050 $0.082 risen by 64%
$40 Application for quotation of securities - IMU 26 Sep 2023 11:41AM $0.051 $0.082 risen by 62.38%
$40 Imugene Closes SPP Raising $18.2 million 25 Sep 2023 9:32AM $0.050 $0.082 risen by 64%
$40 Share Purchase Plan Closing Date Extended 13 Sep 2023 5:13PM $0.060 $0.082 risen by 36.67%
$40 Imugene PD1-Vaxx Update 12 Sep 2023 9:05AM $0.059 $0.082 risen by 38.98%
$40 Imugene Receives Positive Feedback From FDA 11 Sep 2023 8:37AM $0.061 $0.082 risen by 34.43%
$40 Paul Woodard, M.D. appointed as Chief Medical Officer 4 Sep 2023 9:05AM $0.066 $0.082 risen by 24.24%
$40 VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1 4 Sep 2023 8:58AM $0.066 $0.082 risen by 24.24%

276 - 300 of 1188 results

Page 12 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.